Prothena Corp Public (PRTA) Operating Leases (2019 - 2026)
Prothena Corp Public's (PRTA) quarterly Operating Leases came in at $4.8 million in Q1 2026, down 53.34% year-on-year from $10.2 million in Q1 2025, and down 13.23% quarter-over-quarter from $5.5 million in Q4 2025.
Prothena Corp Public (PRTA) Operating Leases (2019 - 2026) Analysis & Trends
Prothena Corp Public's Operating Leases history runs 8 years deep, the most recent figure standing at $4.8 million for Q1 2026.
- On a quarterly basis, Operating Leases fell 53.34% year-over-year to $4.8 million in Q1 2026; TTM through Mar 2026 was $4.8 million, a 53.34% decrease from a year earlier, with the FY2025 full-year figure at $5.5 million, down 33.35% from the prior year.
- Operating Leases declined to $4.8 million in Q1 2026 per PRTA's latest filing, from $5.5 million in the prior quarter.
- Across five years, Operating Leases topped out at $12.5 million in Q1 2024 and bottomed at $3.4 million in Q2 2023.
- The 5-year median for Operating Leases is $9.3 million (2024), against an average of $8.6 million.
- Across the five-year window, Operating Leases tumbled 64.0% in 2023 and surged 176.62% in 2024, its largest moves.
- Year by year, Operating Leases stood at $8.0 million in 2022, then surged by 33.45% to $10.7 million in 2023, then slipped by 23.21% to $8.2 million in 2024, then slumped by 33.35% to $5.5 million in 2025, then slipped by 13.23% to $4.8 million in 2026.
- Per Business Quant, the three latest PRTA Operating Leases figures stand at $4.8 million (Q1 2026), $5.5 million (Q4 2025), and $9.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Prothena Corp Public | 467.80 Mn | 138.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.76 Mn |
| Dec 31, 2025 | 5.49 Mn |
| Sep 30, 2025 | 9.08 Mn |
| Jun 30, 2025 | 9.78 Mn |
| Mar 31, 2025 | 10.20 Mn |
| Dec 31, 2024 | 8.23 Mn |
| Sep 30, 2024 | 11.49 Mn |
| Jun 30, 2024 | 9.54 Mn |
| Mar 31, 2024 | 12.50 Mn |
| Dec 31, 2023 | 10.72 Mn |
| Sep 30, 2023 | 8.92 Mn |
| Jun 30, 2023 | 3.45 Mn |
| Mar 31, 2023 | 4.89 Mn |
| Sep 30, 2022 | 8.03 Mn |
| Jun 30, 2022 | 9.58 Mn |
| Mar 31, 2022 | 10.88 Mn |
| Dec 31, 2021 | 6.39 Mn |
| Sep 30, 2021 | 13.75 Mn |
| Jun 30, 2021 | 9.43 Mn |
| Mar 31, 2021 | 16.50 Mn |